(ANSA) - ROME, FEBRUARY 04 - The first patient in Italy treated with the antiviral pill Paxlovid at the Spallanzani Institute.
This is a 54-year-old man with cardiovascular disease eCovid-19 who has been symptomatic for 3 days.
This was announced by the Spallanzani Institute.
The drug Paxlovid is composed of an antiviral, Nirmatrelvir, a potentiating drug, Ritonavir.
The treatment consists of three tablets in the morning and 3 in the evening, for 5 days.
(HANDLE).
